L
Lorna Kwan
Researcher at University of California, Los Angeles
Publications - 178
Citations - 7387
Lorna Kwan is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 41, co-authored 155 publications receiving 6391 citations.
Papers
More filters
Journal ArticleDOI
Quality of Life at the End of Primary Treatment of Breast Cancer: First Results From the Moving Beyond Cancer Randomized Trial
Patricia A. Ganz,Lorna Kwan,Annette L. Stanton,Janice L. Krupnick,Julia H. Rowland,Beth E. Meyerowitz,Julienne E. Bower,Thomas R. Belin +7 more
TL;DR: Clinical interventions to address common symptoms associated with treatment should be considered to improve physical and emotional functioning at the end of primary treatment for breast cancer.
Journal ArticleDOI
Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?
Julienne E. Bower,Patricia A. Ganz,Michael R. Irwin,Lorna Kwan,Elizabeth C. Breen,Steve W. Cole +5 more
TL;DR: In this article, the authors examined the possibility that inflammatory processes may underlie this constellation of symptoms and found that women treated with chemotherapy endorsed higher levels of all symptoms and also had higher plasma levels of sTNF-RII than women who did not receive chemotherapy (all P <.05).
Journal ArticleDOI
Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology
Jesse D. Le,Nelly Tan,Eugene Shkolyar,David Y. Lu,Lorna Kwan,Leonard S. Marks,Jiaoti Huang,Daniel Margolis,Steven S. Raman,Robert E. Reiter +9 more
TL;DR: It is found that tumor size and grade were important predictors of tumor detection, and although cancer is often multifocal, MRI is often able to detect the worst focus of cancer.
Journal ArticleDOI
Quality of Life After Surgery, External Beam Irradiation, or Brachytherapy for Early-Stage Prostate Cancer
Mark S. Litwin,John L. Gore,Lorna Kwan,Judson M. Brandeis,Steve P. Lee,H. Rodney Withers,Robert E. Reiter +6 more
TL;DR: The primary treatments for clinically localized prostate cancer confer equivalent cancer control for most patients but disparate side effects, and health‐related quality of life outcomes after the most commonly used treatments are compared.